120 patients now in CD12 (s/c trial). Many have di
Post# of 148179
(Total Views: 703)
Posted On: 07/01/2020 12:35:14 PM
120 patients now in CD12 (s/c trial). Many have died from serious adverse events. The question is how many of those deaths would have been avoided if the patients had been treated with Leronlimab. I’m betting a statistically significant number of them.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼